Managing Heart Failure: Cases in Optimal Treatment and Care Coordination Web Activity

Expert Faculty Presenters

Akshay Desai, MD, MPH
Medical Director, Cardiomyopathy and Heart Failure Program, Advanced Heart Disease Section
Brigham and Women's Hospital
Associate Professor
Harvard Medical School
Click here for biography

Jo Ellen Rodgers, PharmD, BCPS, BCCP, FCCP, FHFSA, FAHA, CPP
Director, Postdoctoral Programs
Vice Chair, Professional Education and Practice
UNC Eshelman School of Pharmacy
Click here for biography

Target Audience
This activity is designed to meet the educational needs of pharmacists with an interest managing patients with heart failure.

Statement of Need/Program Overview
Health-system pharmacy and managed care professionals can benefit from ongoing educational efforts that review effective heart failure (HF) management strategies that incorporate the biological, social, environmental, and economic drivers of the disease. Recognizing disparities is the first step to overcoming disparities observed in HF treatment and it will take a concerted effort by those living with HF, providers, and the health-system to ensure equitable health care to all. An increased awareness of effective and safe HF treatment strategies, as well as a better understanding of the social and economic variables that impact HF care delivery, can contribute to improved treatment outcomes for patients with HF within health-system settings.

Educational Objectives

Accreditation Information

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hours (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

UAN: JA4008162-9999-22-072-H01-P
Activity Type: Knowledge

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Name of Working Group Members/Planners

Reported Financial Relationship

Akshay Desai, MD, MPH

Consulting fees (eg. Advisory boards) – Abbott, Alnylam, Amgen, AstraZeneca, Boehringer Ingelheim, Merck, Novartis, Lexicon, Regeneron

Contracted Research – Novartis, AstraZeneca, Alnylam, Bayer, Abbott
Jo Ellen Rodgers, PharmD, BCPS, BCCP, FCCP, FHFSA, FAHA, CPP

Jo Ellen Rodgers, PharmD, BCPS, BCCP, FCCP, FHFSA, FAHA, CPP has nothing to disclose.

The PIM planners and managers have nothing to disclose.
The Impact Education, LLC® planners and managers have nothing to disclose.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

In order to obtain your CPE accreditation, please follow the steps below at the conclusion of the activity:

There is no fee for this educational activity.